Nutriband selects brand name for abuse-deterrent fentanyl patch; will submit to FDA

NutriBand Inc.

Selected commercial worldwide brand name candidate for lead product, a fentanyl transdermal system with abuse-deterrent technology.
Will submit proposed brand name and labeling to FDA and international regulators for review and approval; also filing for trademark registration.
Engaged Brand Institute, global leader with 75% share of drug name approvals and 87% of FDA-approved names in 2024.
Product uses AVERSA abuse-deterrent technology; potential peak annual US sales of $80-200 million per market report.
Brand Institute's regulatory subsidiary DSI, led by former FDA/EMA officials, will provide regulatory support.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.